LC
ZBH icon

Lindbrook Capital’s Zimmer Biomet ZBH Stock Holding History

Lindbrook Capital’s Portfolio ZBH Stock Details ZBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		$220K Buy
1,940
+1,526
+369% +$163K 0.02% 387
2024
Q4 		$43.7K Sell
414
-23
-5% -$2.47K ﹤0.01% 874
2024
Q3 		$47.2K Sell
437
-26
-6% -$2.84K ﹤0.01% 849
2024
Q2 		$50.2K Sell
463
-1,126
-71% -$133K ﹤0.01% 796
2024
Q1 		$210K Buy
1,589
+19
+1% +$2.37K 0.02% 352
2023
Q4 		$191K Buy
1,570
+344
+28% +$38.4K 0.02% 361
2023
Q3 		$138K Sell
1,226
-34
-3% -$4.32K 0.02% 397
2023
Q2 		$183K Buy
1,260
+7
+0.6% +$951 0.02% 343
2023
Q1 		$162K Buy
1,253
+34
+3% +$4.27K 0.02% 363
2022
Q4 		$155K Buy
1,219
+24
+2% +$2.79K 0.02% 388
2022
Q3 		$125K Sell
1,195
-32
-3% -$3.51K 0.02% 387
2022
Q2 		$129K Buy
1,227
+48
+4% +$5.7K 0.02% 394
2022
Q1 		$151K Buy
1,179
+825
+233% +$99.4K 0.02% 359
2021
Q4 		$44K Buy
354
+202
+133% +$26.4K 0.01% 765
2021
Q3 		$22K Sell
152
-23
-13% -$3.38K 0.01% 717
2021
Q2 		$27K Hold
175
– – 0.01% 678
2021
Q1 		$27K Buy
175
+39
+29% +$6.04K 0.01% 645
2020
Q4 		$20K Hold
136
– – ﹤0.01% 690
2020
Q3 		$18K Buy
136
+18
+15% +$2.35K 0.01% 655
2020
Q2 		$14K Sell
118
-8
-6% -$922 ﹤0.01% 734
2020
Q1 		$12K Sell
126
-103
-45% -$13.5K ﹤0.01% 710
2019
Q4 		$33K Buy
229
+20
+10% +$2.76K 0.01% 571
2019
Q3 		$28K Hold
209
– – 0.01% 606
2019
Q2 		$23K Hold
209
– – 0.01% 652
2019
Q1 		$25K Buy
209
+141
+207% +$16K 0.01% 627
2018
Q4 		$6K Buy
+68
New +$7.65K ﹤0.01% 989

Other funds holding ZBH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Lindbrook Capital's ZBH Position: Q1 2025 in Review

Lindbrook Capital increased its Zimmer Biomet (ZBH) stake by 369% in Q1 2025, buying an estimated $163K and bringing the position to 1,940 shares worth $220K. The position accounts for 0.02% of the portfolio, ranked #387.

Lindbrook Capital first reported a position in ZBH in Q4 2018 and has held it in 26 quarters since. 1,003 funds tracked by Wall St. Rank hold ZBH as of Q1 2025.

  • Lindbrook Capital held 1,940 shares of Zimmer Biomet worth $220K as of Q1 2025.
  • Lindbrook Capital bought 1,526 Zimmer Biomet shares in Q1 2025, an estimated $163K.
  • Zimmer Biomet made up 0.02% of Lindbrook Capital's portfolio in Q1 2025, its #387 holding.
  • Lindbrook Capital first reported a position in Zimmer Biomet in Q4 2018 and has held it in 26 quarters since.
  • 1,003 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2025.

Based on Lindbrook Capital's 13F filing for Q1 2025, filed 5 May 2025.